Who backs Areteia Therapeutics?
11 investors| Investor | Type |
|---|---|
| Viking Global Investors | Asset manager |
| GV | Venture capital |
| ARCH Venture Partners | Venture capital |
| Marshall Wace | Hedge fund |
| Maverick Capital | Hedge fund |
| Bain Capital Life Sciences | Venture capital |
| Access Biotechnology | — |
| Population Health Partners | — |
| Sanofi | — |
| Saturn Partners | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Areteia Therapeutics investors
11 investors are on record for Areteia Therapeutics, including Viking Global Investors, GV, ARCH Venture Partners and Marshall Wace. By type, the record holds 3 venture capital firms, 2 hedge funds and 1 asset manager. The Series A1 in Feb 2024 drew 9 investors.
Free account
More of Areteia Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Areteia Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Areteia Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View